E

Researcher Profile

Elena Hitraya

🏛 Crescendo Bioscience Inc., South San Francisco, CA, USA

3

Publications

26

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article Journal of the American Academy of Dermatology Jan 01, 2026

Safety and efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the phase 2 STRIDE study

Kim A. Papp · Shahram Jacobs · Howard Sofen · Michael Bukhalo +7 more

10.1016/j.jaad.2025.10.005 3 citations

Open Access Journal Article Journal of the American Academy of Dermatology Jan 01, 2026

Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging phase 2 study

Andrew Blauvelt · Petr Arenberger · Maxwell B. Sauder · Megan Couvillion +7 more

10.1016/j.jaad.2025.07.013 6 citations

Open Access Journal Article Rheumatology Dec 24, 2018

Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis

Jeffrey R Curtis · Darl D Flake · Michael E Weinblatt · Nancy A Shadick +14 more

10.1093/rheumatology/key367 17 citations

Publication Timeline

2026

2

2018

1

Frequent Co-Authors

Andrew Blauvelt

Petr Arenberger

Michelle Bettinger

Cecilie Heegaard Brahe